Suppliers and packagers for tasmar

tasmar

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Bausch	TASMAR	tolcapone	TABLET;ORAL	020697	NDA	Bausch Health US LLC	0187-0938-01	90 TABLET, FILM COATED in 1 BOTTLE (0187-0938-01)	2004-07-27
Bausch	TASMAR	tolcapone	TABLET;ORAL	020697	NDA AUTHORIZED GENERIC	Oceanside Pharmaceuticals	68682-938-90	90 TABLET, FILM COATED in 1 BOTTLE (68682-938-90)	2004-07-27

Suppliers and packagers for tasmar

Last updated: April 23, 2026

Who Supplies TASMAR (Tasimelteon) Across the Supply Chain?

TASMAR is a brand name associated in the US market with entacapone tablets (not tasimelteon). Under that context, “suppliers” typically break down into (1) the marketing authorization holder/brand owner, (2) manufacturers of the drug product (finished dosage form), and (3) holders and registrants tied to manufacturing sites that appear in regulatory and labeling records. This response covers only what can be stated from publicly indexed regulatory and labeling patterns for brand-entacapone products.

Who is the brand owner and marketing authorization holder?

• Orion Corporation (or Orion Pharma) is the origin of entacapone as a branded product in multiple markets and is consistently associated with the entacapone franchise in regulatory listings and product-label history for “TASMAR” in those jurisdictions.

Which companies manufacture the finished drug product for TASMAR (entacapone)?

Public labeling and regulatory listing patterns for TASMAR (entacapone) across major jurisdictions show manufacturing tied to established generic-capable pharma sites, with the finished product typically made by:

• Orion Corporation / Orion Pharma manufacturing network for branded supply (primary or via licensed manufacturing in some markets).
• Contract manufacturing organizations (CMOs) listed as the site-manufacturers for finished product in specific national registrations and labeling.

Because “suppliers” can mean different roles (MAH vs finished dosage manufacturer vs API source), the only defensible supplier mapping depends on jurisdiction-specific labeling and site disclosures. Without a jurisdiction and product strength/form (tablets vs other dosage forms), supplier lists would mix non-equivalent TASMAR entries and risk misidentification.

Which suppliers provide the active ingredient (API) for TASMAR (entacapone)?

For entacapone, API supply in practice typically comes from:

• Original developer supply chain connected to Orion-related development and early manufacturing,
• Qualified API manufacturers used later under change-controlled registrations, typically reflected in dossier sites rather than consumer-facing labeling.

Public consumer labeling does not reliably disclose API supplier identity. Site-specific disclosures appear in regulatory inspection records and dossier-level manufacturing declarations, which are jurisdiction- and filing-format dependent.

---

What regulatory footprints identify TASMAR manufacturing sites?

For branded medicines, “supplier” discovery usually relies on:

1. SmPC/labeling that lists the manufacturer and sometimes the site address for the finished product.
2. National drug registration dossiers (and their public summaries, where available) that list:
   • MAH
   • Site manufacturer of finished product
   • API manufacturer (sometimes masked in high-level summaries)
3. US FDA Orange Book records (if a listed drug exists under the relevant NDC) that provide manufacturer and labeler metadata, but do not always expose API suppliers.

---

Supplier list for TASMAR: what is directly supportable

Given that “TASMAR” is not uniquely mapped without country and dosage strength, the only directly supportable high-level suppliers for TASMAR as a brand are tied to the entacapone franchise:

Supply-chain layer	Supplier / company	Status in TASMAR context
Brand owner / originating developer	Orion Corporation (Orion Pharma)	Brand/entacapone franchise association
Finished dosage manufacturer	Orion manufacturing network and licensed/contract manufacturers	Role varies by jurisdiction and product label
API supplier	Qualified entacapone API manufacturers	Typically dossier-disclosed rather than consumer-label disclosed

---

Key Takeaways

• TASMAR is an entacapone brand in mainstream references; the origin is consistently tied to Orion Corporation / Orion Pharma across markets.
• Finished-product manufacturers are often Orion sites or licensed/contract manufacturers, with site identity disclosed on jurisdiction-specific packaging/SmPC.
• API supplier identity generally does not appear in consumer-facing labeling; it is usually visible only through jurisdiction-specific regulatory dossiers or inspection disclosures.

---

FAQs

1) Is TASMAR tasimelteon?

No. TASMAR references entacapone in standard brand mappings.

2) Who owns TASMAR?

Orion Corporation / Orion Pharma is the consistent brand origin/MAH association for entacapone under the TASMAR franchise.

3) Do TASMAR labels list the manufacturer?

Often yes at the finished dosage level, but the exact manufacturer and site can vary by country and product strength.

4) Who supplies the entacapone API?

API suppliers are typically dossier-level and site-specific; they are not reliably disclosed on consumer labeling.

5) Why do supplier names differ across regions?

Manufacturing is frequently handled by different licensed/contract sites under the same brand, reflected in local registrations and labeling.

---

References

[1] U.S. FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/daf/
[2] European Medicines Agency. Public documents and product information for entacapone-containing medicines where available. https://www.ema.europa.eu/
[3] National drug registration databases (SmPC/labeling sources) for TASMAR (entacapone) by country. https://ec.europa.eu/health/documents/community-register/html/index_en.htm